Director's Notes This issue of Milestones highlights some of our scientific advances in FY 2021-2022. Read More
A New Application for an Old Medicine Regular aspirin use may limit prostate cancer metastasis in African American men. Read More
Decades in the Making New drug proves effective at shrinking von Hippel-Lindau-associated tumors. Read More
Boosted by Bacteria Gut bacteria promote anti-cancer immunity by activating a key innate immune signaling pathway. Read More
One-Two Punch for Cancer A new algorithm to SELECT the best therapy helps advance precision oncology. Read More
Good for Bladder Cancer, Better for Kidney Cancer A novel drug combination becomes the standard of care for kidney cancer. Read More
Why Age is an Advantage Surprisingly, young immune systems may support breast cancer metastasis to the brain. Read More
Deciphering DNA Clues Genetic analyses improve the detection and diagnosis of childhood cancers. Read More
Protection Strategy An unusual means of chromosome protection sheds light on cancer cell growth. Read More
Reining in Rogue Immune Cells FDA approves new treatment for chronic graft-versus-host disease. Read More
Gelling Together Against Cancer Surgeons and chemists team up to create a new hydrogel for treating mesothelioma. Read More
Better Microbes, Better Immunotherapy Microbial transplants can lead to a better immunotherapy response. Read More
New Faculty New faculty join CCR each year to contribute to our work of making breakthrough scientific discoveries to find cures and treatments for cancer. We also recognize current faculty who have started new roles within CCR. Read More
Awards & Honors We are proud of our CCR awardees who represent a spectacular array of accomplishments. Read More
By the Numbers Take a look at our year as told by the numbers to see a snapshot of the breakthrough scientific discoveries and important work happening at CCR. Read More